Skip to main content
Fig. 2 | BMC Public Health

Fig. 2

From: Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs

Fig. 2

Impact of MCCV program in the UK (Incidence rate reduction comparing pre-and-post-vaccination periods). MCCV program introduced in the NIP in 1999 (at 2, 3, 4 months of age). Subsequest schedules changes were made in 2006 (at 3, 4 months), 2013 (at 2, 12 months; 13–14 years); 2015 (MCCV at 2, 12 months; MCV4 at 13–14 years); 2016 (infant MCCV doseat 2 months was removed)

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us